Sexual Health & Hormones
PT-141
A peptide studied to support desire and arousal in both men and women
from $249/mo
What it is
A considered protocol.
PT-141, also known as bremelanotide, is a compounded peptide studied for its role in supporting sexual desire and arousal in both men and women. Rather than acting on blood flow alone, it is designed to work through nervous-system pathways tied to desire. At Orvo, it is reviewed individually by a licensed U.S. provider and compounded in a U.S. pharmacy before being delivered discreetly to your door.
How it works
The mechanism, plainly.
PT-141 takes a different path than most sexual-health options — one studied through the brain and nervous system rather than the bloodstream.
Signals desire pathways
It is designed to engage melanocortin receptors in the nervous system that are involved in sexual desire and arousal.
Supports a natural response
By engaging these pathways, it may support the body's own arousal response rather than acting only on circulation.
Used as guided
Providers typically time use around anticipated activity, with a plan tailored to your history and goals.
Candidacy
A considered fit, not a funnel.
PT-141 may suit adults looking to support desire and arousal who prefer an approach that works through the nervous system. A provider helps determine whether it fits your overall health picture.
- Adults seeking support for low libido
- Men and women wanting arousal support
- Those preferring a non-blood-flow approach
- Anyone pregnant, breastfeeding, or planning pregnancy
- Those with current or prior cancer
- People with uncontrolled high blood pressure or cardiovascular disease
Your concierge support
A licensed clinician, matched to you.
Every peptide protocol is coordinated end to end by our licensed care team — reviewed individually, adjusted as you go, and never handed off to a rotating call center.
- 01Compounded medication
- Prepared by partner compounding pharmacies and shipped on a structured cadence.
- 02Dedicated provider
- Every interaction is coordinated directly by our licensed care team — not a rotating callcenter.
- 03Provider-directed dosing
- Titration and adjustments at every transition under expert clinical supervision.
- 04Direct message access
- Reach your provider directly between scheduled check-ins via your secure patient portal.
- 05Structured check-ins
- Cadenced reviews to keep your protocol and overall care plan calibrated to your response.
- 06Discreet direct delivery
- Temperature-controlled, unmarked packaging delivered direct to your door.
Clinical safety
No therapy is right for everyone.
Common side effects
Reported effects may include nausea, flushing, headache, and temporary reactions at the injection site. A licensed provider monitors your response and adjusts the plan as needed.
Who should not use it
PT-141 is not appropriate during pregnancy, breastfeeding, or while planning pregnancy, or with a history of cancer, uncontrolled high blood pressure, cardiovascular disease, stroke, or clotting disorders. It is used with caution alongside antihypertensives, nitrates, alpha-blockers, or antidepressants, and is not combined with current ED medication or hormone therapy. Your full medical history is reviewed before any prescription is authorized.
Orvo Health protocols are prepared by partner compounding pharmacies in the United States. Compounding pharmacies are regulated by both state boards and the FDA and have been part of American medicine since long before mass-manufactured drugs existed. The active ingredient is prepared per your protocol — supervised by your provider — and delivered direct to your door.
Begin assessment
PT-141 begins with a short assessment.
A licensed provider reviews every order. If it's right for you, your protocol is compounded by a partner U.S. pharmacy and delivered discreetly to your door.